◆ SpookStack

' FD-302a (Rev. 10-6-95) @ . © 279A-WE-222936-USAMRIID b b 27 Continuation of FD-302 of | _] ,On 04/11/2008 ,Page 3 mb OS of experiments in order to optimize the Ba powder in the same consistency as the recovered Ba evidence. When asked to provide an opinion as to who RIID had the greatest capability to purify wet spores| | sesponded that fF BRUCE: IVINS were the most capable.[—_—sd| reiterated again that did not think it was possible for an employee at ‘USAMRTID to have produced the anthrax powder, mainly because laboratory space was extremely crowded and therefore it would be impossible for the perpetrator to maintain aoe while producing such a large volume of purified Ba spores. described IVINS as just an "odd duck," someone who is very benign. approximated the L__] budget. in 1995 to be in the area of 1.5 million dollars and that by 2002 the budget had risen to approximately 8 million dollars. intimated that funding ~ was always a constant issue at USAMRIID and implied that there was nothing abnormal about that. By 2002,[ __] explained that USAMRIID's customer base had grown significantly to include research requests from entities.such as; Department of Homeland Security, Health and Human Services, and various other law enforcement entities specifically recalled providing support back in the 1999 time frame to the Federal Bureau of Investigation pertaining to bi volume of hoax and mock biological terrorist attacks] recalled this time period as providing an excellent opportunity to prepare for a terrorist attack. - described the 1995 time frame at USAMRIID as being "tough years" as[__]recalled the closing of the annex laboratory on base that resulted in many USAMRIID Divisions having to consolidate resources.[___]specifically recalled a time period in the late 1990's and early 2000 that the Bacteriology Division's vaccine developmental programs were under funded primarily due to the anticipation that both the anthrax and plaque vaccine products were transitioning over to the advanced development stage. The - recombinant Protective Antigen (rPA) anthrax vaccine. had itioned over to the Joint Vaccine Acquisition Program (JVAP) . Ce could not recall any specific instances of an outwardly display of frustration on the part of Bacteriology Division employees; however, characterized Bacteriology Division employee frustration and_discontentment as simply “hallway talk" around\the water coolers. recalled some frustration exhibited b , in part due to some resentment an rustration shared by Bacteriology Division researchers due to the increased amount of effort having to expend